M. Garin

The apolipoprotein ε2 allele and the severity of coronary artery disease in Type 2 diabetic patients

R. James, B. Kalix, M. Meynet, 2001 .

Paraoxonase polymorphism in non-insulin dependent diabetes: A link between lipid oxidation and coronary heart disease

P. Froguel, H. Blanché, P. Passa, 1995 .

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

G. Charpentier, P. Froguel, H. Blanché, 1995, The Lancet.

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

P. Froguel, H. Blanché, P. Passa, 1997, The Journal of clinical investigation.

Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome.

A. Morabia, R. James, B. Kalix, 2005, The Journal of clinical endocrinology and metabolism.

Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.

P. Froguel, P. Passa, I. Leviev, 2000, Diabetes.

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

C. Abbott, C. Abbott, P. Durrington, 1994, The Biochemical journal.

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

A. von Eckardstein, M. Taskinen, G. Assmann, 1998, Atherosclerosis.